168 related articles for article (PubMed ID: 3003067)
1. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
Galizzi JP; Borsotto M; Barhanin J; Fosset M; Lazdunski M
J Biol Chem; 1986 Jan; 261(3):1393-7. PubMed ID: 3003067
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
Galizzi JP; Fosset M; Lazdunski M
Biochem Biophys Res Commun; 1985 Oct; 132(1):49-55. PubMed ID: 2998366
[TBL] [Abstract][Full Text] [Related]
3. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
[TBL] [Abstract][Full Text] [Related]
4. A novel high affinity class of Ca2+ channel blockers.
Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
[TBL] [Abstract][Full Text] [Related]
5. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
Reynolds IJ; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
[TBL] [Abstract][Full Text] [Related]
6. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
7. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
[TBL] [Abstract][Full Text] [Related]
8. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
Balwierczak JL; Johnson CL; Schwartz A
Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
[TBL] [Abstract][Full Text] [Related]
10. Calcium channels: basic properties as revealed by radioligand binding studies.
Glossmann H; Ferry DR; Goll A; Striessnig J; Schober M
J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S20-30. PubMed ID: 2414589
[TBL] [Abstract][Full Text] [Related]
11. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates.
Galizzi JP; Fosset M; Lazdunski M
Eur J Biochem; 1984 Oct; 144(2):211-5. PubMed ID: 6092067
[TBL] [Abstract][Full Text] [Related]
12. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
13. (-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites.
Ferry DR; Goll A; Gadow C; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):183-7. PubMed ID: 6092974
[TBL] [Abstract][Full Text] [Related]
14. Allosteric interaction of semotiadil fumarate, a novel benzothiazine, with 1,4-dihydropyridines, phenylalkylamines, and 1,5-benzothiazepines at the Ca(2+)-channel antagonist binding sites in canine skeletal muscle membranes.
Nakayama K; Nozawa Y; Fukuta Y
J Cardiovasc Pharmacol; 1994 May; 23(5):731-40. PubMed ID: 7521455
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
[TBL] [Abstract][Full Text] [Related]
16. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
[TBL] [Abstract][Full Text] [Related]
17. Purified calcium channels have three allosterically coupled drug receptors.
Striessnig J; Goll A; Moosburger K; Glossmann H
FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161
[TBL] [Abstract][Full Text] [Related]
18. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
Kanngiesser U; Pongs O
Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
[TBL] [Abstract][Full Text] [Related]
19. Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles.
Pang DC; Sperelakis N
Eur J Pharmacol; 1983 Feb; 87(2-3):199-207. PubMed ID: 6601581
[TBL] [Abstract][Full Text] [Related]
20. Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110.
Borsotto M; Barhanin J; Norman RI; Lazdunski M
Biochem Biophys Res Commun; 1984 Aug; 122(3):1357-66. PubMed ID: 6089781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
